Arthritis, rheumatoid Trials in Whittier, United States
Conditions / Arthritis, rheumatoid / Whittier, United States
Clinical trials for Arthritis, rheumatoid investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01856309 | Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 | COMPLETED | PHASE3 |
| NCT01604343 | A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) | COMPLETED | PHASE3 |
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | COMPLETED | PHASE3 |
| NCT01004432 | Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) | COMPLETED | PHASE3 |
| NCT02137226 | BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01606761 | A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) | COMPLETED | PHASE3 |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT00346216 | Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen | COMPLETED | PHASE4 |
| NCT02019472 | A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT04333147 | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) | TERMINATED | PHASE3 |